Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. - Wikidata - wikimedia - TriplyDB

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

http://www.wikidata.org/entity/Q36866566

about

Nutrition and the risk of Alzheimer's disease Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products The Role of Oxidative Stress in Neurodegenerative Diseases Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration Oxidative Stress in Neurodegenerative Diseases The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system Coenzyme Q10 and α-tocopherol reversed age-associated functional impairments in mice.Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Ascorbic acid and the brain: rationale for the use against cognitive decline.Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.Coenzyme q10 therapy Neuronal injury from cardiac arrest: aging years in minutes.Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.Influence of lifestyle modifications on age-related free radical injury to brain.Nutrition and prevention of Alzheimer's dementia.Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration.Vitamin E for Alzheimer's dementia and mild cognitive impairment.Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.Progress in Alzheimer's disease research in the last year.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.How to design nutritional intervention trials to slow cognitive decline in apparently healthy populations and apply for efficacy claims: a statement from the International Academy on Nutrition and Aging Task Force.Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease.Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations.Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study Dietary Alpha-Lipoic Acid Alters Piglet Neurodevelopment.Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial.Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders.Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.

P2860

Q22241959-1783B7DF-76CE-43BA-B530-085ACBBFB004 Q26744105-F32B2A1C-3512-42BB-A64E-C7859092E367 Q26767051-5541ED8E-9C89-4021-AA54-8AF5CE8835D5 Q26771758-F7EE2B53-C61F-4310-AE78-F71630CDDF72 Q26800963-57724BF9-9381-4900-8A8F-4D6E4EFEB65F Q26801239-05073164-CA24-47EC-84B7-CD6A3DB30E3E Q28074531-C9AA21DC-3999-4017-94FB-F298762F0A6A Q28389419-B7B9CB18-0A57-460B-9759-3A17FFE78772 Q30401821-9D9E3219-6607-4947-8A87-19F90B836A4A Q30779251-6AC514B6-8705-4023-8A32-DCE92EAF62E5 Q33556068-588280EE-EA26-4088-A18F-E558BCED7C5C Q33570528-6DE19097-A84D-4989-9398-DDFD6F0BDBAD Q33608218-82FD5593-93E4-4434-A8CC-7F139D0A844F Q33614523-2E614698-3BFA-41FA-82C6-01FE3168E999 Q33956936-EBCD4E64-3549-48A2-8671-8EC6D1B432D7 Q34116168-3DD20B20-50A5-4EA4-9A90-4BE1A97CBB30 Q34123865-B06CE93E-AFA5-4A96-A61A-1F39749DE70C Q34160762-233B190A-15E0-4E61-A82E-58CE3FDE921E Q34369234-8DE97E1B-F3DD-4E9B-A9B5-9D1AAB7B00D0 Q34458474-430D8235-7B0F-4678-AC86-AE77C37E6C5E Q34550138-8ABE56D9-EE2B-44CA-AE63-6EDE6776C42F Q34551041-24672F5B-654E-4CD0-918D-5F7E372C6BB4 Q34675868-87D1C295-99FF-4682-98F5-3E7351832AAD Q34685307-5FE4CEF3-BAC6-4BA6-946C-AEAAB16E7EEA Q35034114-9B996DCB-E297-4369-AE43-F891D31FA3E5 Q35752353-D844AC2C-6DD2-4F1E-B5EB-48A54FDD737F Q35764820-3CFB66A5-484F-4CE4-859B-562E06584982 Q35800000-2BD08CA3-BC4B-491D-8FBF-600CE48CE183 Q36205039-DD91541B-1E78-4AAC-96E0-E1AE53DB69F5 Q36271462-C22A8A4B-6994-4E17-86C9-323AF17544A2 Q36337525-B81CB2D5-D92F-4775-82DF-DEBB8B75ED5A Q36421954-02827626-41C5-4A5A-86DB-032E12EC0885 Q36553760-676C600C-8A7A-4E1C-9FAF-B8594E574EB1 Q36599276-A1A2559B-5A30-449C-84C9-B2D8766B1BF1 Q36632830-B8616954-BF84-4B9D-AAE2-06BAB88CDC43 Q36874654-B058B911-7BC3-41E9-BF07-0BFFA3C6DE0D Q36963311-542CD325-8EE5-41F9-BD3B-BFB60AEBF1E3 Q37244943-92101A75-6C47-43F2-BE49-FB213AC9017F Q37361122-9E161F9A-7363-4A5C-92A0-AC1C4299E43E Q37456775-4AE50457-CAE2-429A-8070-57420C93A2B5

P2860

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

http://www.wikidata.org/entity/Q36866566

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Antioxidants for Alzheimer dis ...... inal fluid biomarker measures.

@en

type

label

Antioxidants for Alzheimer dis ...... inal fluid biomarker measures.

@en

prefLabel

Antioxidants for Alzheimer dis ...... inal fluid biomarker measures.

@en

P1433

Q36866566-41A0D959-62AD-42A7-A277-CBAA1AD7042E

P1476

Q36866566-1784B61C-845C-4002-9142-DD397C8869C6

P2093

Q36866566-240DAD57-00CA-4EE4-9407-4C7207B39079

Q36866566-2E1534B3-97C0-4094-BADE-38AD459D13DF

Q36866566-49CF43EB-0918-474C-BA02-F4F7064E8594

Q36866566-549CE09D-C549-4E30-855F-92E0E4C4E711

Q36866566-5937E343-7F75-4BD6-9F59-13D504B24AE6

Q36866566-75760976-622F-410E-9D06-AFC50194B540

Q36866566-7FE8B993-CA7D-4919-88D6-50E1B7122551

Q36866566-9F95BEC7-459A-4BA2-9FF6-A3E07D3FCC5B

Q36866566-D25433C0-D7F3-4B76-AA94-B34D570518B4

Q36866566-E12B867B-97F8-4EA7-AA9A-1EFD943E785C

P2860

Q36866566-0D985390-EDE6-473E-8AF3-68B0BE59935E

Q36866566-0EEFFA5A-E0B4-441D-9007-ADC5813D9720

Q36866566-2AC4AFB7-A317-42C1-8DDA-0781A3B3B636

Q36866566-2D0C92F6-6B64-48E3-8D53-C261A3DD1494

Q36866566-2E4867B7-40EB-4700-9AF6-26643E41F368

Q36866566-3259E07C-7CCD-43C8-9049-96B02AEBED80

Q36866566-3E8B46FE-D28E-44EE-83E6-7B809A348130

Q36866566-44269ED1-D6BB-498F-968D-8993A5717997

Q36866566-536C6D49-905A-425A-B1A3-5BE3E45D848C

Q36866566-5ABA759D-FF7D-4CD8-91FC-FBC7ABEF378F

P304

Q36866566-C6E4F2AA-2B8F-4968-A140-7D82DA889D4B

P31

Q36866566-5A20AB0A-FF0C-4572-82C6-4942D5757597

P356

Q36866566-1F4F0ADD-8F1B-4714-BAE0-C10306D7B8E4

P433

Q36866566-AF400F75-0A04-460A-AFC5-98BBCC328DA3

P478

Q36866566-682C0684-5C37-465E-A0D7-EC4E545D267C

P50

Q36866566-40EF5A60-B4B9-48A7-9C4B-2681019E4D9A

P577

Q36866566-AF5C36C0-0819-42FA-9664-865E45F397F9

P698

Q36866566-F1405F65-B6C4-42D5-ADE9-1DADC68456CB

P921

Q36866566-3CDC9BB4-22F2-40B9-9695-A8958BB3DD10

Q36866566-8B44D21A-849E-4348-AD7B-F4BCEAD52085

Q36866566-D8FD9408-7457-442D-92D6-75E4918AD451

P932

Q36866566-D035870B-BE8A-47AD-A184-17FF1178D5CD

P356

ARCHNEUROL.2012.85

P1433

P1476

Antioxidants for Alzheimer dis ...... inal fluid biomarker measures.

@en

P2093

Alzheimer’s Disease Cooperative Study

http://www.w3.org/2001/XMLSchema#string

Barbara Cottrell

http://www.w3.org/2001/XMLSchema#string

Carl Cotman

http://www.w3.org/2001/XMLSchema#string

Christopher M Clark

http://www.w3.org/2001/XMLSchema#string

Douglas R Galasko

http://www.w3.org/2001/XMLSchema#string

Elaine Peskind

http://www.w3.org/2001/XMLSchema#string

Gregory A Jicha

http://www.w3.org/2001/XMLSchema#string

John M Ringman

http://www.w3.org/2001/XMLSchema#string

Joseph F Quinn

http://www.w3.org/2001/XMLSchema#string

Ronald G Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

The role of biomarkers in clinical trials for Alzheimer disease

Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

P304

836-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2012.85

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22431837

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

3661272

http://www.w3.org/2001/XMLSchema#string